Ehab M Khalil

Title: Ehab M Khalil: Innovator in Histone Acetyltransferase Inhibitors

Introduction

Ehab M Khalil is a notable inventor based in Bronx, NY (US). He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for histone acetyltransferases and serotonin N-acetyltransferase. With a total of 2 patents, his work has implications for therapeutic processes in human health.

Latest Patents

Khalil's latest patents include "Inhibitors of histone acetyltransferases (HATs) and uses thereof." This invention focuses on histone acetyltransferase inhibitors that differentiate between p300 and PCAF histone acetyltransferase, along with therapeutic processes for their administration to humans. Another significant patent is "Inhibitors of serotonin N-acetyltransferase," which describes a compound that inhibits serotonin N-acetyltransferase and includes a pharmaceutical composition with a suitable carrier. This invention relates to novel compounds and analogs that inhibit the serotonin N-acetyltransferase enzyme and outlines processes for their preparation.

Career Highlights

Throughout his career, Ehab M Khalil has worked with prestigious institutions, including The Rockefeller University. His research has contributed to advancements in understanding and treating various health conditions through innovative biochemical approaches.

Collaborations

Khalil has collaborated with esteemed colleagues such as Philip A Cole and Raymond E Soccio, further enhancing the impact of his research in the scientific community.

Conclusion

Ehab M Khalil's work in developing inhibitors for histone acetyltransferases and serotonin N-acetyltransferase showcases his innovative spirit and dedication to advancing medical science. His contributions are vital for future therapeutic applications.